Related Experiment Video
Updated: Nov 26, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
NF-κB-mediated lncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating
Ze-Nan Zheng1, Guang-Zhao Huang1, Qing-Qing Wu1
1Department of Oral & Maxillofacial Surgery, NanFang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Abstract:
Oral squamous cell carcinoma (OSCC) is the most common oral cancer. The molecular mechanisms of this disease are not fully understood. Our previous studies confirmed that dysregulated function of long non-coding RNA (lncRNA) AC007271.3 was associated with a poor prognosis and overexpression of AC007271.3 promoted cell proliferation, migration, invasion, and inhibited cell apoptosis in vitro, and promoted tumor growth in vivo. However, the underlying mechanisms of AC007271.3 dysregulation remained obscure. In this study, our investigation showed that AC007271.3 functioned as competing endogenous RNA by binding to miR-125b-2-3p and by destabilizing primary miR-125b-2, resulted in the upregulating expression of Slug, which is a direct target of miR-125b-2-3p. Slug also inhibited the expression of E-cadherin but N-cadherin, vimentin, and β-catenin had no obvious change. The expression of AC007271.3 was promoted by the canonical nuclear factor-κB (NF-κB) pathway. Taken together, these results suggested that the classical NF-κB pathway-activated AC007271.3 regulates EMT by miR-125b-2-3p/Slug/E-cadherin axis to promote the development of OSCC, implicating it as a novel potential target for therapeutic intervention in this disease.
Insights
Long non-coding RNA AC007271.3 promotes oral cancer by activating the NF-κB pathway. This lncRNA (long non-coding RNA) regulates epithelial-mesenchymal transition via the miR-125b-2-3p/Slug/E-cadherin axis, offering a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oral squamous cell carcinoma (OSCC) is a prevalent cancer with incompletely understood molecular drivers.
- Previous research identified long non-coding RNA (lncRNA) AC007271.3 as a prognostic marker and promoter of OSCC progression in vitro and in vivo.
- The precise mechanisms underlying AC007271.3 dysregulation in OSCC remained unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms by which AC007271.3 contributes to OSCC development.
- To investigate the role of AC007271.3 as a competing endogenous RNA (ceRNA) in OSCC.
- To identify upstream regulators and downstream targets of AC007271.3 in the context of OSCC.
Main Methods:
- Investigated AC007271.3's interaction with miR-125b-2-3p and its effect on Slug expression.
- Analyzed the impact of Slug on epithelial-mesenchymal transition (EMT) markers, including E-cadherin.
- Examined the regulation of AC007271.3 expression by the nuclear factor-κB (NF-κB) pathway.
Main Results:
- AC007271.3 acts as a ceRNA, sequestering miR-125b-2-3p and leading to increased Slug expression.
- Slug upregulation resulted in decreased E-cadherin expression, indicative of EMT.
- The canonical NF-κB pathway was identified as a promoter of AC007271.3 expression.
Conclusions:
- The NF-κB pathway-activated AC007271.3 promotes OSCC development by regulating EMT via the miR-125b-2-3p/Slug/E-cadherin axis.
- AC007271.3 represents a novel molecular target for therapeutic interventions in oral squamous cell carcinoma.
- Understanding this pathway provides critical insights into OSCC pathogenesis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Induced Pluripotent Stem Cells
Somatic...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation